Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT03954509 Recruiting - Cancer Clinical Trials

Needs Assessment of Cancer Patients With Complementary and Alternative Medicines

MAC'EVAL
Start date: July 1, 2018
Phase:
Study type: Observational

The chronic cancer status, multidisciplinary and ambulatory care, as well as the cumbersome effects of the disease and treatments, lead patients to consider other options than those offered by traditional medicine, such as alternative medicine and complementary (CAM)

NCT ID: NCT03951428 Recruiting - Cancer Clinical Trials

Screening of Cancer Through Novel Female Specific Biomarkers

Start date: May 15, 2019
Phase:
Study type: Observational

Can reliable biomarkers be identified for detection of cancer at early stages using menstrual blood (MB)? Preliminary mass spectrometry (MS) results suggest that MB provides biomarkers for identification of disease such as cancers.

NCT ID: NCT03947294 Recruiting - Cancer Clinical Trials

The ICALIC 2 International Multicentric Study

ICALIC2
Start date: May 6, 2019
Phase:
Study type: Observational

Clinicians need to measure energy expenditure (EE) by indirect calorimetry (IC) to optimize nutritional support for a better clinical outcome, especially in patients with chronic conditions or with high risk of under- and over- feeding. However, IC is rarely used in clinical routine because the devices currently on the market are of tedious use, imprecise and expensive. An easy-to-use, accurate and inexpensive IC device (Q-NRG® CE marking n°MED 9811) has been developed to meet specifications made by and for clinicians. The ease of use of this new IC device has been first evaluated in mechanical ventilation mode. This second phase aims at evaluating the ease of use, the stability and the feasibility of the measurements with this new IC device in canopy and face mask modes for spontaneously breathing adult patients.

NCT ID: NCT03946800 Recruiting - Cancer Clinical Trials

A Study of MEDI1191 Alone and in Combination With Durvalumab in Subjects With Advanced Solid Tumors

Start date: May 8, 2019
Phase: Phase 1
Study type: Interventional

To evaluate MEDI1191 administered intratumorally alone and in combination with intravenous durvalumab in patients with solid tumors

NCT ID: NCT03945734 Recruiting - Cancer Clinical Trials

Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

Start date: May 9, 2019
Phase: N/A
Study type: Interventional

This study examines the feasibility, cultural-sensitivity, and health effects of the expressive helping intervention by conducting a single-arm trial with Chinese-speaking cancer patients and survivors.

NCT ID: NCT03944447 Recruiting - Cancer Clinical Trials

Outcomes Mandate National Integration With Cannabis as Medicine

OMNI-Can
Start date: December 1, 2018
Phase:
Study type: Observational [Patient Registry]

This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.

NCT ID: NCT03937934 Recruiting - Obesity Clinical Trials

Study Title: Food Rx

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if subjects with lack of access to healthy food and a long term health problem, are helped by a weekly box of healthy groceries and nutrition education.

NCT ID: NCT03936400 Recruiting - Cancer Clinical Trials

Development of Therapeutic Conversations With Females Diagnosed With Cancer and Their Partners

Start date: April 15, 2017
Phase: N/A
Study type: Interventional

The main purpose of the doctoral study is to better understand the experience of cancer diagnosis and treatment in how it effects sexuality and intimacy of the female cancer patient and her partner.

NCT ID: NCT03934957 Recruiting - Obesity Clinical Trials

Hamburg City Health Study - a German Cohort Study

HCHS
Start date: February 8, 2016
Phase:
Study type: Observational

The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several risk and prognostic factors in major chronic diseases.

NCT ID: NCT03928938 Recruiting - Cancer Clinical Trials

Follow-up of Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy by Electronic Patient Reported Outcomes-tool

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Electronic patient reported outcome (ePRO) tools have improved survival and quality of life (QoL) of cancer patients receiving chemotherapy, and in the follow-up of lung cancer patients. Current study investigates electronic patient reported outcome tool in the follow-up of cancer patients receiving immune checkpoint inhibitor therapy. Current study aims to evaluate 1) patient reported symptoms and their severity, 2) Number of triggered alerts by the tool and their correlation to treatment side-effects, cancer progression, other medical events or survival, 3) Correlation between different symptoms and the correlation of symptoms to treatment side-effects, cancer progression, other medical events or survival,4) QoL of patients and correlation of changes in QoL to treatment side-effects, cancer progression, other medical events or survival, 5) Patient compliance, 6) Correlation of baseline laboratory values to treatment side-effects, cancer progression, other medical events or survival.